Real-World Effectiveness of Long-Acting Injectable and Oral Antipsychotic Agents in US Medicare Patients with Schizophrenia.
作者:
主题词
人类(Humans);抗精神病药(Antipsychotic Agents);美国(United States);男(雄)性(Male);女(雌)性(Female);精神分裂症(Schizophrenia);投药, 口服(Administration, Oral);迟效制剂(Delayed-Action Preparations);Medicare(Medicare);中年人(Middle Aged);老年人(Aged);注射(Injections);住院(Hospitalization);服药依从性(Medication Adherence);治疗结果(Treatment Outcome);成年人(Adult);利哌立酮(Risperidone)
DOI
10.1007/s12325-024-03075-6
PMID
39812753
发布时间
2025-02-04
- 浏览0

Advances in therapy
1251-1264页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文